Market research
NC6.AU Nanollose Limited
AU AUD Consumer Cyclical
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 32M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.72
Community
Investor discussion
1 comment
Sign in to join the NC6.AU discussion.
5 years, 5 months ago
Nanollose Limited is currently in a long term downtrend where the price is trading 2.8% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Nanollose Limited's total revenue sank by 66.9% to $2K since the same quarter in the previous year.
Its net income has increased by 25.0% to $-441K since the same quarter in the previous year.
Finally, its free cash flow fell by 28.6% to $-347K since the same quarter in the previous year.
Based on the above factors, Nanollose Limited gets an overall score of 2/5.